Follow
Xia Tao
Xia Tao
Fresenius Medical Care North America
Verified email at rriny.com
Title
Cited by
Cited by
Year
Removal of protein-bound uremic toxins during hemodialysis using a binding competitor
M Madero, KB Cano, I Campos, X Tao, V Maheshwari, J Brown, ...
Clinical Journal of the American Society of Nephrology 14 (3), 394-402, 2019
1052019
Improved dialytic removal of protein-bound uraemic toxins with use of albumin binding competitors: an in vitro human whole blood study
X Tao, S Thijssen, P Kotanko, CH Ho, M Henrie, E Stroup, G Handelman
Scientific reports 6 (1), 23389, 2016
732016
In silico comparison of protein-bound uremic toxin removal by hemodialysis, hemodiafiltration, membrane adsorption, and binding competition
V Maheshwari, S Thijssen, X Tao, DH Fuertinger, F Kappel, P Kotanko
Scientific Reports 9 (1), 909, 2019
352019
Enhanced indoxyl sulfate dialyzer clearance with the use of binding competitors
X Tao, S Thijssen, N Levin, P Kotanko, G Handelman
Blood purification 39 (4), 323-330, 2015
312015
A novel mathematical model of protein-bound uremic toxin kinetics during hemodialysis
V Maheshwari, S Thijssen, X Tao, D Fuertinger, F Kappel, P Kotanko
Scientific Reports 7, 2017
272017
Tryptophan and kynurenine levels and its association with sleep, nonphysical fatigue, and depression in chronic hemodialysis patients
R Malhotra, V Persic, W Zhang, J Brown, X Tao, L Rosales, S Thijssen, ...
Journal of Renal Nutrition 27 (4), 260-266, 2017
252017
Removal of protein-bound uremic toxins using binding competitors in hemodialysis: a narrative review
V Maheshwari, X Tao, S Thijssen, P Kotanko
Toxins 13 (9), 622, 2021
192021
Clearance of p-cresol sulfate and β-2-microglobulin from dialysate by commercially available sorbent technology
A Kruse, X Tao, V Bhalani, G Handelman, NW Levin, P Kotanko, ...
ASAIO journal 57 (3), 219-224, 2011
122011
Performance of the surprise question compared to prediction models in hemodialysis patients: a prospective study
R Malhotra, X Tao, Y Wang, Y Chen, RH Apruzzese, P Balter, Q Xiao, ...
American Journal of Nephrology 46 (5), 390-396, 2017
92017
SARS-CoV-2 in spent dialysate from chronic peritoneal dialysis patients with COVID-19
PKNG Xiaoling Wang, Amrish Patel, Lela Tisdale, Zahin Haq, Xiaoling Ye ...
7*
The membrane perspective of uraemic toxins: which ones should, or can, be removed?
SK Bowry, P Kotanko, R Himmele, X Tao, M Anger
Clinical Kidney Journal 14 (Supplement_4), i17-i31, 2021
62021
Effect of statewide lockdown in response to Covid-19 pandemic on physical activity levels of hemodialysis patients
M Han, P Preciado, O Thwin, X Tao, LM Tapia-Silva, LR Fuentes, ...
Blood Purification 50 (4-5), 602-609, 2021
52021
A model-based analysis of phenytoin and carbamazepine toxicity treatment using binding-competition during hemodialysis
V Maheshwari, RS Hoffman, S Thijssen, X Tao, DH Fuertinger, P Kotanko
Scientific Reports 10 (1), 11294, 2020
52020
Estimation of fluid status using three multifrequency bioimpedance methods in hemodialysis patients
LC Wang, JG Raimann, X Tao, P Preciado, O Thwin, L Rosales, ...
Hemodialysis International 26 (4), 575-587, 2022
32022
Systems and methods for analyzing spent dialysate
P Kotanko, X Tao, MG Garbaccio, S Thijssen, N Grobe, LMT Silva
US Patent App. 16/739,366, 2021
32021
Transfer of low-molecular weight single-stranded DNA through the membrane of a high-flux dialyzer
X Tao, N Hoenich, SK Handelman, NW Levin, P Kotanko, GJ Handelman
The International Journal of Artificial Organs 37 (7), 529-538, 2014
22014
Identification of arterial oxygen intermittency in oximetry data
PP Galuzio, A Cherif, X Tao, O Thwin, H Zhang, S Thijssen, P Kotanko
Scientific Reports 12 (1), 16023, 2022
12022
Intradialytic monitoring of hemodynamic status based on detection of oxygen signature phase shift
P Kotanko, S Thijssen, P Preciado, ID Campos, X Tao
US Patent 11,744,930, 2023
2023
Removal of Middle Molecules and Dialytic Albumin Loss: A Cross-over Study of Medium Cutoff and High-Flux Membranes with Hemodialysis and Hemodiafiltration
A Armenta-Alvarez, S Lopez-Gil, I Osuna, N Grobe, X Tao, GF Dias, ...
Kidney360 4 (8), 1095-1102, 2023
2023
Techniques for modelling and optimizing dialysis toxin displacer compounds
X Tao, V Maheshwari, P Kotanko, S Thijssen, N Grobe
US Patent App. 18/128,557, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20